Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN11 | Q06124 | 4/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | APAF1 | O14727 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | NQO2 | P16083 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16572269 | 0.82 | PTPN11 (0.56) | PTPN11NPC1RAB9AMAPTKMT2A | |
| SCHEMBL15715193 | 0.82 | SMN1; SMN2 (0.39) | PTPN11NPC1RAB9AMAPTKMT2A | |
| SCHEMBL8807216 | 0.82 | CD44 (0.41) | PTPN11NPC1RAB9AMAPTKMT2A | |
| SCHEMBL8317152 | 0.82 | PTPN11 (0.61) | PTPN11NPC1RAB9AMAPTKMT2A | |
| SCHEMBL15624690 | 0.78 | NQO2 (0.42) | NPC1RAB9AMAPTKMT2AMEN1 | |
| SCHEMBL14666981 | 0.77 | PTPN11 (0.33) | PTPN11MAPTKMT2AMEN1ALDH1A1 | |
| SCHEMBL14282437 | 0.75 | KMT2A (0.46) | PTPN11MAPTKMT2AMEN1ALDH1A1 | |
| SCHEMBL766925 | 0.75 | PTPN11 (0.39) | PTPN11NPC1RAB9AMAPTKMT2A | |
| SCHEMBL762002 | 0.73 | PTPN11 (0.54) | PTPN11NPC1RAB9AMAPTKMT2A | |
| SCHEMBL15834089 | 0.71 | UHRF1 (0.38) | PTPN11MAPTKMT2AMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0858102-B1 | Surface treatment composition and method for treating surface of substrate by using the same | MITSUBISHI CHEM CORP (JP) | 2007-07-25 | — | — | EP | claimed |
| CN-118530715-A | Aggregation-induced emission fluorescent microsphere, preparation method thereof and test strip | 广州医科大学 | 2024-08-23 | — | — | CN | disclosed |
| US-12043749-B2 | Method for producing ink composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-07-23 | — | — | US | disclosed |
| US-12043749-B2 | Method for producing ink composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-07-23 | — | — | US | disclosed |
| US-11917839-B2 | High signal-to-noise ratio photoelectric conversion element | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-02-27 | — | — | US | disclosed |
| US-11917839-B2 | High signal-to-noise ratio photoelectric conversion element | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-02-27 | — | — | US | disclosed |
| US-20240023422-A1 | COMPOSITION, FILM, ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, AND PHOTODETECTION ELEMENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-01-18 | — | — | US | disclosed |
| US-20240023422-A1 | COMPOSITION, FILM, ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, AND PHOTODETECTION ELEMENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-01-18 | — | — | US | disclosed |
| US-11877459-B2 | Light detecting element | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-01-16 | — | — | US | disclosed |
| US-11877459-B2 | Light detecting element | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-01-16 | — | — | US | disclosed |
| EP-2241548-A1 | Vanadium di-nuclear complex | Sumitomo Chemical Company, Limited (JP) | 2010-10-20 | — | — | EP | disclosed |
| EP-2241547-A1 | Method for producing aromatic compound polymer | Sumitomo Chemical Company, Limited (JP) | 2010-10-20 | — | — | EP | disclosed |
| US-20100210619-A1 | 6-Amino-Pyrimidine-4-Carboxamide Derivatives and Related Compounds Which Bind to the Sphingosine 1-Phosphate (S1P) Receptor for the Treatment of Multiple Sclerosis | MERCK SERONO SA (CH) | 2010-08-19 | — | — | US | disclosed |
| US-20100210619-A1 | 6-Amino-Pyrimidine-4-Carboxamide Derivatives and Related Compounds Which Bind to the Sphingosine 1-Phosphate (S1P) Receptor for the Treatment of Multiple Sclerosis | MERCK SERONO SA (CH) | 2010-08-19 | — | — | US | disclosed |
| US-20100137362-A1 | HETEROCYCLIC HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-03 | — | — | US | disclosed |
| US-7534503-B2 | Monomer for use in preparation of a polymer to be used in optical devices | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2009-05-19 | — | — | US | disclosed |
| US-7534503-B2 | Monomer for use in preparation of a polymer to be used in optical devices | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2009-05-19 | — | — | US | disclosed |
| WO-2009019167-A1 | 6-AMINO-PYRIMIDINE-4-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS WHICH BIND TO THE SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR FOR THE TREATMENT OF MULTIPLE SCLEROSIS | MERCK SERONO S.A. (CH) | 2009-02-12 | — | — | WO | disclosed |
| US-20090018309-A1 | Method for Producing Aromatic Compound Polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-01-15 | — | — | US | disclosed |
| EP-1767560-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | Sumitomo Chemical Company, Limited (JP) | 2007-03-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018309-A1 | Method for Producing Aromatic Compound Polymer | PAH, MAOA, AHR | PTPN11 4290/4885NPC1 3935/4885RAB9A 3951/4885 |
| US-20100210619-A1 | 6-Amino-Pyrimidine-4-Carboxamide Derivatives and Related Compounds Which Bind to the Sphingosine 1-Phosphate (S1P) Receptor for the Treatment of Multiple Sclerosis | S1PR1, S1PR5, S1PR3 | PTPN11 2513/4885NPC1 2759/4885RAB9A 2733/4885 |
| US-20100137362-A1 | HETEROCYCLIC HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME | ACHE, CAT, DNPH1 | PTPN11 1590/4885NPC1 1902/4885RAB9A 658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.